aluates Reports

$ 0.0

Automative

Global mRNA Delivery System Market Research Report 2026

Published Date: 2026-01-21

Report Code: QYRE-Auto-37G18831

Global mRNA Delivery System Market Research Report 2024

BUY CHAPTERS

Global mRNA Delivery System Market Research Report 2026

Code: QYRE-Auto-37G18831

Report

2026-01-21

Pages:101

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Moderna, Inc

Arbutus

Evonik Industries

AIM Vaccine

Innorna

Genevant

Suzhou Abogen Biosciences

Jiachen Xihai(Hangzhou)Biotechnology

Longuide Biopharma Corporation

mRNA Delivery System Market Size

The global mRNA Delivery System market was valued at US$ 1009 million in 2025 and is anticipated to reach US$ 1590 million by 2032, at a CAGR of 6.8% from 2026 to 2032.

mRNA Delivery System Market

mRNA has a large molecular weight and strong hydrophilicity, but its single stranded structure makes it extremely unstable and easily degraded. It carries a negative charge and is difficult to deliver through cell membranes with negative charges on the surface. Therefore, special modification or encapsulation delivery systems are required to achieve intracellular expression of mRNA. Delivery technology is the core patented technology of mRNA companies. Lipid nanoparticles (LNP) are currently the mainstream delivery carrier method. Due to its easy absorption by antigen-presenting cells, it is most commonly used in vaccines, and currently the three major mRNA vaccine giants have adopted LNP delivery technology. In addition, there are cationic lipid complexes (LPX), lipid polymer complexes (LPP) Polymer nanoparticles (PNP), inorganic nanoparticles (INP), cationic nanoemulsions (CNE), as well as the GalNac N-acetylgalactosamine technology independently developed by Ruibo Biotechnology, can be used for targeted delivery to the liver.

The North American market for mRNA Delivery System is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for mRNA Delivery System is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for mRNA Delivery System in Vaccine Development is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of mRNA Delivery System include Moderna, Genevant, Arbutus, Evonik Industries, Suzhou Abogen Biosciences, AIM Vaccine, InnoRNA, Jiachen Xihai(Hangzhou)Biotechnology, Longuide Biopharma Corporation, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global mRNA Delivery System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding mRNA Delivery System. The mRNA Delivery System market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global mRNA Delivery System market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist mRNA Delivery System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of mRNA Delivery System Market Report

Report Metric	Details
Report Name	mRNA Delivery System Market
Accounted market size in 2025	US$ 1009 million
Forecasted market size in 2032	US$ 1590 million
CAGR	6.8%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	LNP Delivery PNP Delivery Others
Segment by Application	Vaccine Development Gene Therapy Protein Replacement Therapy Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Moderna, Genevant, Arbutus, Evonik Industries, Suzhou Abogen Biosciences, AIM Vaccine, InnoRNA, Jiachen Xihai(Hangzhou)Biotechnology, Longuide Biopharma Corporation
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for mRNA Delivery System companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is mRNA Delivery System Market growing?

Ans: The mRNA Delivery System Market witnessing a CAGR of 6.8% during the forecast period 2026-2032.

What is the mRNA Delivery System Market size in 2032?

Ans: The mRNA Delivery System Market size in 2032 will be US$ 1590 million.

Who are the main players in the mRNA Delivery System Market report?

Ans: The main players in the mRNA Delivery System Market are Moderna, Genevant, Arbutus, Evonik Industries, Suzhou Abogen Biosciences, AIM Vaccine, InnoRNA, Jiachen Xihai(Hangzhou)Biotechnology, Longuide Biopharma Corporation

What are the Application segmentation covered in the mRNA Delivery System Market report?

Ans: The Applications covered in the mRNA Delivery System Market report are Vaccine Development, Gene Therapy, Protein Replacement Therapy, Others

What are the Type segmentation covered in the mRNA Delivery System Market report?

Ans: The Types covered in the mRNA Delivery System Market report are LNP Delivery, PNP Delivery, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global mRNA Delivery System Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 LNP Delivery

1.2.3 PNP Delivery

1.2.4 Others

1.3 Market by Application

1.3.1 Global mRNA Delivery System Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Vaccine Development

1.3.3 Gene Therapy

1.3.4 Protein Replacement Therapy

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global mRNA Delivery System Market Perspective (2021–2032)

2.2 Global mRNA Delivery System Growth Trends by Region

2.2.1 Global mRNA Delivery System Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 mRNA Delivery System Historic Market Size by Region (2021–2026)

2.2.3 mRNA Delivery System Forecasted Market Size by Region (2027–2032)

2.3 mRNA Delivery System Market Dynamics

2.3.1 mRNA Delivery System Industry Trends

2.3.2 mRNA Delivery System Market Drivers

2.3.3 mRNA Delivery System Market Challenges

2.3.4 mRNA Delivery System Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top mRNA Delivery System Players by Revenue

3.1.1 Global Top mRNA Delivery System Players by Revenue (2021–2026)

3.1.2 Global mRNA Delivery System Revenue Market Share by Players (2021–2026)

3.2 Global Top mRNA Delivery System Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by mRNA Delivery System Revenue

3.4 Global mRNA Delivery System Market Concentration Ratio

3.4.1 Global mRNA Delivery System Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by mRNA Delivery System Revenue in 2025

3.5 Global Key Players of mRNA Delivery System Head Offices and Areas Served

3.6 Global Key Players of mRNA Delivery System, Products and Applications

3.7 Global Key Players of mRNA Delivery System, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 mRNA Delivery System Breakdown Data by Type

4.1 Global mRNA Delivery System Historic Market Size by Type (2021–2026)

4.2 Global mRNA Delivery System Forecasted Market Size by Type (2027–2032)

5 mRNA Delivery System Breakdown Data by Application

5.1 Global mRNA Delivery System Historic Market Size by Application (2021–2026)

5.2 Global mRNA Delivery System Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America mRNA Delivery System Market Size (2021–2032)

6.2 North America mRNA Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America mRNA Delivery System Market Size by Country (2021–2026)

6.4 North America mRNA Delivery System Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe mRNA Delivery System Market Size (2021–2032)

7.2 Europe mRNA Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe mRNA Delivery System Market Size by Country (2021–2026)

7.4 Europe mRNA Delivery System Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific mRNA Delivery System Market Size (2021–2032)

8.2 Asia-Pacific mRNA Delivery System Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific mRNA Delivery System Market Size by Region (2021–2026)

8.4 Asia-Pacific mRNA Delivery System Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America mRNA Delivery System Market Size (2021–2032)

9.2 Latin America mRNA Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America mRNA Delivery System Market Size by Country (2021–2026)

9.4 Latin America mRNA Delivery System Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa mRNA Delivery System Market Size (2021–2032)

10.2 Middle East & Africa mRNA Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa mRNA Delivery System Market Size by Country (2021–2026)

10.4 Middle East & Africa mRNA Delivery System Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Moderna

11.1.1 Moderna Company Details

11.1.2 Moderna Business Overview

11.1.3 Moderna mRNA Delivery System Introduction

11.1.4 Moderna Revenue in mRNA Delivery System Business (2021–2026)

11.1.5 Moderna Recent Development

11.2 Genevant

11.2.1 Genevant Company Details

11.2.2 Genevant Business Overview

11.2.3 Genevant mRNA Delivery System Introduction

11.2.4 Genevant Revenue in mRNA Delivery System Business (2021–2026)

11.2.5 Genevant Recent Development

11.3 Arbutus

11.3.1 Arbutus Company Details

11.3.2 Arbutus Business Overview

11.3.3 Arbutus mRNA Delivery System Introduction

11.3.4 Arbutus Revenue in mRNA Delivery System Business (2021–2026)

11.3.5 Arbutus Recent Development

11.4 Evonik Industries

11.4.1 Evonik Industries Company Details

11.4.2 Evonik Industries Business Overview

11.4.3 Evonik Industries mRNA Delivery System Introduction

11.4.4 Evonik Industries Revenue in mRNA Delivery System Business (2021–2026)

11.4.5 Evonik Industries Recent Development

11.5 Suzhou Abogen Biosciences

11.5.1 Suzhou Abogen Biosciences Company Details

11.5.2 Suzhou Abogen Biosciences Business Overview

11.5.3 Suzhou Abogen Biosciences mRNA Delivery System Introduction

11.5.4 Suzhou Abogen Biosciences Revenue in mRNA Delivery System Business (2021–2026)

11.5.5 Suzhou Abogen Biosciences Recent Development

11.6 AIM Vaccine

11.6.1 AIM Vaccine Company Details

11.6.2 AIM Vaccine Business Overview

11.6.3 AIM Vaccine mRNA Delivery System Introduction

11.6.4 AIM Vaccine Revenue in mRNA Delivery System Business (2021–2026)

11.6.5 AIM Vaccine Recent Development

11.7 InnoRNA

11.7.1 InnoRNA Company Details

11.7.2 InnoRNA Business Overview

11.7.3 InnoRNA mRNA Delivery System Introduction

11.7.4 InnoRNA Revenue in mRNA Delivery System Business (2021–2026)

11.7.5 InnoRNA Recent Development

11.8 Jiachen Xihai(Hangzhou)Biotechnology

11.8.1 Jiachen Xihai(Hangzhou)Biotechnology Company Details

11.8.2 Jiachen Xihai(Hangzhou)Biotechnology Business Overview

11.8.3 Jiachen Xihai(Hangzhou)Biotechnology mRNA Delivery System Introduction

11.8.4 Jiachen Xihai(Hangzhou)Biotechnology Revenue in mRNA Delivery System Business (2021–2026)

11.8.5 Jiachen Xihai(Hangzhou)Biotechnology Recent Development

11.9 Longuide Biopharma Corporation

11.9.1 Longuide Biopharma Corporation Company Details

11.9.2 Longuide Biopharma Corporation Business Overview

11.9.3 Longuide Biopharma Corporation mRNA Delivery System Introduction

11.9.4 Longuide Biopharma Corporation Revenue in mRNA Delivery System Business (2021–2026)

11.9.5 Longuide Biopharma Corporation Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Moderna, Inc

Arbutus

Evonik Industries

AIM Vaccine

Innorna

Genevant

Suzhou Abogen Biosciences

Jiachen Xihai(Hangzhou)Biotechnology

Longuide Biopharma Corporation

List of Tables

Table 1. Global mRNA Delivery System Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of LNP Delivery

Table 3. Key Players of PNP Delivery

Table 4. Key Players of Others

Table 5. Global mRNA Delivery System Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global mRNA Delivery System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global mRNA Delivery System Market Size by Region (US$ Million), 2021–2026

Table 8. Global mRNA Delivery System Market Share by Region (2021–2026)

Table 9. Global mRNA Delivery System Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global mRNA Delivery System Market Share by Region (2027–2032)

Table 11. mRNA Delivery System Market Trends

Table 12. mRNA Delivery System Market Drivers

Table 13. mRNA Delivery System Market Challenges

Table 14. mRNA Delivery System Market Restraints

Table 15. Global mRNA Delivery System Revenue by Players (US$ Million), 2021–2026

Table 16. Global mRNA Delivery System Market Share by Players (2021–2026)

Table 17. Global Top mRNA Delivery System Players by Tier (Tier 1, Tier 2, and Tier 3), based on mRNA Delivery System Revenue, 2025

Table 18. Ranking of Global Top mRNA Delivery System Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by mRNA Delivery System Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of mRNA Delivery System, Headquarters and Area Served

Table 21. Global Key Players of mRNA Delivery System, Products and Applications

Table 22. Global Key Players of mRNA Delivery System, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global mRNA Delivery System Market Size by Type (US$ Million), 2021–2026

Table 25. Global mRNA Delivery System Revenue Market Share by Type (2021–2026)

Table 26. Global mRNA Delivery System Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global mRNA Delivery System Revenue Market Share by Type (2027–2032)

Table 28. Global mRNA Delivery System Market Size by Application (US$ Million), 2021–2026

Table 29. Global mRNA Delivery System Revenue Market Share by Application (2021–2026)

Table 30. Global mRNA Delivery System Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global mRNA Delivery System Revenue Market Share by Application (2027–2032)

Table 32. North America mRNA Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America mRNA Delivery System Market Size by Country (US$ Million), 2021–2026

Table 34. North America mRNA Delivery System Market Size by Country (US$ Million), 2027–2032

Table 35. Europe mRNA Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe mRNA Delivery System Market Size by Country (US$ Million), 2021–2026

Table 37. Europe mRNA Delivery System Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific mRNA Delivery System Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific mRNA Delivery System Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific mRNA Delivery System Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America mRNA Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America mRNA Delivery System Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America mRNA Delivery System Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa mRNA Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa mRNA Delivery System Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa mRNA Delivery System Market Size by Country (US$ Million), 2027–2032

Table 47. Moderna Company Details

Table 48. Moderna Business Overview

Table 49. Moderna mRNA Delivery System Product

Table 50. Moderna Revenue in mRNA Delivery System Business (US$ Million), 2021–2026

Table 51. Moderna Recent Development

Table 52. Genevant Company Details

Table 53. Genevant Business Overview

Table 54. Genevant mRNA Delivery System Product

Table 55. Genevant Revenue in mRNA Delivery System Business (US$ Million), 2021–2026

Table 56. Genevant Recent Development

Table 57. Arbutus Company Details

Table 58. Arbutus Business Overview

Table 59. Arbutus mRNA Delivery System Product

Table 60. Arbutus Revenue in mRNA Delivery System Business (US$ Million), 2021–2026

Table 61. Arbutus Recent Development

Table 62. Evonik Industries Company Details

Table 63. Evonik Industries Business Overview

Table 64. Evonik Industries mRNA Delivery System Product

Table 65. Evonik Industries Revenue in mRNA Delivery System Business (US$ Million), 2021–2026

Table 66. Evonik Industries Recent Development

Table 67. Suzhou Abogen Biosciences Company Details

Table 68. Suzhou Abogen Biosciences Business Overview

Table 69. Suzhou Abogen Biosciences mRNA Delivery System Product

Table 70. Suzhou Abogen Biosciences Revenue in mRNA Delivery System Business (US$ Million), 2021–2026

Table 71. Suzhou Abogen Biosciences Recent Development

Table 72. AIM Vaccine Company Details

Table 73. AIM Vaccine Business Overview

Table 74. AIM Vaccine mRNA Delivery System Product

Table 75. AIM Vaccine Revenue in mRNA Delivery System Business (US$ Million), 2021–2026

Table 76. AIM Vaccine Recent Development

Table 77. InnoRNA Company Details

Table 78. InnoRNA Business Overview

Table 79. InnoRNA mRNA Delivery System Product

Table 80. InnoRNA Revenue in mRNA Delivery System Business (US$ Million), 2021–2026

Table 81. InnoRNA Recent Development

Table 82. Jiachen Xihai(Hangzhou)Biotechnology Company Details

Table 83. Jiachen Xihai(Hangzhou)Biotechnology Business Overview

Table 84. Jiachen Xihai(Hangzhou)Biotechnology mRNA Delivery System Product

Table 85. Jiachen Xihai(Hangzhou)Biotechnology Revenue in mRNA Delivery System Business (US$ Million), 2021–2026

Table 86. Jiachen Xihai(Hangzhou)Biotechnology Recent Development

Table 87. Longuide Biopharma Corporation Company Details

Table 88. Longuide Biopharma Corporation Business Overview

Table 89. Longuide Biopharma Corporation mRNA Delivery System Product

Table 90. Longuide Biopharma Corporation Revenue in mRNA Delivery System Business (US$ Million), 2021–2026

Table 91. Longuide Biopharma Corporation Recent Development

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

Table 95. Authors List of This Report

List of Figures

Figure 1. mRNA Delivery System Picture

Figure 2. Global mRNA Delivery System Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global mRNA Delivery System Market Share by Type: 2025 vs 2032

Figure 4. LNP Delivery Features

Figure 5. PNP Delivery Features

Figure 6. Others Features

Figure 7. Global mRNA Delivery System Market Size by Application (US$ Million), 2021–2032

Figure 8. Global mRNA Delivery System Market Share by Application: 2025 vs 2032

Figure 9. Vaccine Development Case Studies

Figure 10. Gene Therapy Case Studies

Figure 11. Protein Replacement Therapy Case Studies

Figure 12. Others Case Studies

Figure 13. mRNA Delivery System Report Years Considered

Figure 14. Global mRNA Delivery System Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global mRNA Delivery System Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global mRNA Delivery System Market Share by Region: 2025 vs 2032

Figure 17. Global mRNA Delivery System Market Share by Players in 2025

Figure 18. Global mRNA Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by mRNA Delivery System Revenue in 2025

Figure 20. North America mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America mRNA Delivery System Market Share by Country (2021–2032)

Figure 22. United States mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe mRNA Delivery System Market Share by Country (2021–2032)

Figure 26. Germany mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific mRNA Delivery System Market Share by Region (2021–2032)

Figure 34. China mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America mRNA Delivery System Market Share by Country (2021–2032)

Figure 42. Mexico mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa mRNA Delivery System Market Share by Country (2021–2032)

Figure 46. Israel mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE mRNA Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Moderna Revenue Growth Rate in mRNA Delivery System Business (2021–2026)

Figure 50. Genevant Revenue Growth Rate in mRNA Delivery System Business (2021–2026)

Figure 51. Arbutus Revenue Growth Rate in mRNA Delivery System Business (2021–2026)

Figure 52. Evonik Industries Revenue Growth Rate in mRNA Delivery System Business (2021–2026)

Figure 53. Suzhou Abogen Biosciences Revenue Growth Rate in mRNA Delivery System Business (2021–2026)

Figure 54. AIM Vaccine Revenue Growth Rate in mRNA Delivery System Business (2021–2026)

Figure 55. InnoRNA Revenue Growth Rate in mRNA Delivery System Business (2021–2026)

Figure 56. Jiachen Xihai(Hangzhou)Biotechnology Revenue Growth Rate in mRNA Delivery System Business (2021–2026)

Figure 57. Longuide Biopharma Corporation Revenue Growth Rate in mRNA Delivery System Business (2021–2026)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global mRNA Vaccines Therapeutics Market Research Report 2024

Global Lipid Nanoparticle LNP Production Equipment Market Research Report 2024

Global Lipid Nanoparticle LNP Raw Material Market Research Report 2024

Global mRNA Vaccine And Therapeutics Market Insights Forecast to 2030

Global Lipid Nanoparticles LNP Market Research Report 2024

Global mRNA Cancer Vaccines and Therapeutics Market Insights Forecast to 2030

Global RNA LNP Lipid Nanoparticle Formulation Market Research Report 2024

Global RNA Vaccines Market Insights Forecast to 2030

Global mRNA Therapy Market Research Report 2024

Global Nanoparticle Drug Delivery Systems Market Research Report 2024

Global Lipid Nanoparticle LNP Formulation Service Market Research Report 2025

Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Research Report 2024

Global Lipid Nanoparticle LNP Development Service Market Research Report 2025

Global Lipid Nanoparticle LNP Formulation Market Research Report 2024

Nucleic Acid Delivery Excipients Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lipid Nanoparticle LNP Synthesis Services Market Research Report 2025

Global Lipid Contract Manufacturing Market Research Report 2024

Global mRNA Treatment Market Research Report 2024

Global Polymer Nanoparticles PNP Formulation Development Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions